Union Mutual Fund, which previously held 1.37 percent of Acutaas Chemicals Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in its stake below the 1 percent reporting requirement.
A research and development-driven manufacturer of specialty chemicals, Acutaas Chemical produces Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients for new chemical entities and innovative drug formulations. The company also supplies materials for agrochemicals and fine chemicals, serving global pharmaceutical and chemical industries. Its distinctive strength lies in vertically integrated manufacturing capabilities and specialized compound development through rigorous in-house research and technical expertise.
Joint venture between Union Bank of India and Da-Ichi Life Insurance of Japan. Manages over Rs 30,000 crore. A smaller AMC with steady growth driven by Union Bank's branch network. Known for equity and hybrid fund offerings targeting conservative retail savers aligned with Union Bank's customer base.